{
  "type": "add_node",
  "timestamp": "2025-08-15T02:20:32",
  "processed": false,
  "inputs": {
    "source_article_id": "R1VQLWGSQ",
    "status": "rejected",
    "reject_category": "macro_driver",
    "reject_failure_cat": "industry_vertical"
  },
  "details": {
    "llm_topic_proposal_raw": {
      "motivation": "The article discusses the implications of GLP-1 medications like Ozempic on health and weight management, highlighting their relevance in the context of macro health trends and potential market impacts, thus warranting a dedicated node.",
      "id": "glp1_medications",
      "name": "GLP-1 Medications",
      "type": "macro",
      "level": "driver"
    },
    "topic_category": {
      "category": "macro_driver",
      "motivation": "GLP‑1 medications are a key driver of macro health trends and influence market dynamics in the pharmaceutical and obesity‑treatment sectors."
    },
    "relevance_gate": {
      "should_add": false,
      "reason": "GLP-1 medications are a specific drug category, not a macro driver, tradable asset, or policy regime; they represent an industry vertical.",
      "confidence": 0.95,
      "failure_category": "industry_vertical"
    }
  },
  "id": "none"
}